Global Autoimmune Disease Diagnostics research

Autoimmune Disease Diagnostics Comprehensive Study by Type (Systemic Diagnostics {Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus, Others}, Localized Diagnostics {Multiple Sclerosis, Type 1 Diabetes, Hashimoto's Thyroiditis, Idiopathic Thrombocytopenic Purpura, Others}), Application (Hospitals, Diagnostic And Research Labs, Research Centers), Disease Type (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjögren’s Syndrome, Thyroiditis, Scleroderma, Other Diseases), Product (Consumables & Assay Kits, Instruments), Test Type (Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test, Other Tests) Players and Region - Global Market Outlook to 2030

Autoimmune Disease Diagnostics Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Autoimmune Disease Diagnostics
Autoimmune Disease Diagnostics is used to treat autoimmune diseases that occur when the immune system attacks one or more cells of the body which are functioning normally owing to the irregularities. As per a secondary source, Autoimmune diseases affect approximately 23.5 million Americans. The United States has the highest prevalence of diagnosed autoimmune conditions followed by Europe and China. The growing incidence of autoimmune disorder such as type 1 diabetes, multiple sclerosis, psoriasis and other will drive the market size in the coming years.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States and European Players will contribute the maximum growth to Global Autoimmune Disease Diagnostics market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Thermo Fisher Scientific (United States), Siemens (Germany), Abbott (United States), Danaher (United States), Bio-Rad Laboratories (United States), Grifols (Spain), Trinity Biotech (Ireland), Werfen (Spain), HYCOR Biomedical (United States), EUROIMMUN AG (Germany), Oncimmune (United Kingdom), HTG Molecular Diagnostics (United States) and Seramun Diagnostica GmbH (Germany) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Exagen Inc. (United States), Cambridge Life Sciences Limited (United Kingdom), A. Menarini Diagnostics s.r.l (Italy), ORGENTEC Diagnostika (Germany), KRONUS (United States) and AESKU GROUP GMBH & CO. KG (Germany)..

Segmentation Overview
AMA Research has segmented the market of Global Autoimmune Disease Diagnostics market by Type (Systemic Diagnostics {Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus, Others} and Localized Diagnostics {Multiple Sclerosis, Type 1 Diabetes, Hashimoto's Thyroiditis, Idiopathic Thrombocytopenic Purpura, Others}), Application (Hospitals, Diagnostic And Research Labs and Research Centers) and Region.



On the basis of geography, the market of Autoimmune Disease Diagnostics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Disease Type, the sub-segment i.e. Rheumatoid Arthritis will boost the Autoimmune Disease Diagnostics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Product, the sub-segment i.e. Consumables & Assay Kits will boost the Autoimmune Disease Diagnostics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Test Type, the sub-segment i.e. Routine Laboratory Tests will boost the Autoimmune Disease Diagnostics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Upsurge In The Number Of Reagent Rental Agreements

Market Growth Drivers:
High Prevalence Of Autoimmune Diseases and Growing Aging Population, Increasing Occurrence Of Rheumatoid Arthritis and Need For The Rapid Detection Of Autoimmune Diseases

Challenges:
Lack Of Skilled Healthcare Professionals

Restraints:
High Capital Requirements and Long Waiting Time For Diagnostic Tests Results

Opportunities:
Increasing Research Activities, Initiatives To Increase Patient Awareness and Use Of Biosensors For Autoimmune Disease Diagnosis

Market Leaders and their expansionary development strategies
In December 2023, QIAGEN and Personalis started partnership combines QIAGEN's expertise in autoimmune disease research with Personalis' liquid biopsy technology to develop new diagnostic tests.
In November 2023,Roche launches Elecsys Anti-Nuclear Antibody (ANA) Profile 7. This automated, multiplex assay streamlines the diagnosis of autoimmune diseases like lupus by simultaneously testing for seven common ANA specificities.


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Autoimmune Disease Diagnostics Providers, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End Users

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Systemic Diagnostics {Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus, Others}
  • Localized Diagnostics {Multiple Sclerosis, Type 1 Diabetes, Hashimoto's Thyroiditis, Idiopathic Thrombocytopenic Purpura, Others}
By Application
  • Hospitals
  • Diagnostic And Research Labs
  • Research Centers
By Disease Type
  • Rheumatoid Arthritis
  • Systemic Lupus Erythematosus
  • Sjögren’s Syndrome
  • Thyroiditis
  • Scleroderma
  • Other Diseases

By Product
  • Consumables & Assay Kits
  • Instruments

By Test Type
  • Routine Laboratory Tests
  • Inflammatory Markers
  • Autoantibodies & Immunologic Test
  • Other Tests

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. High Prevalence Of Autoimmune Diseases and Growing Aging Population
      • 3.2.2. Increasing Occurrence Of Rheumatoid Arthritis
      • 3.2.3. Need For The Rapid Detection Of Autoimmune Diseases
    • 3.3. Market Challenges
      • 3.3.1. Lack Of Skilled Healthcare Professionals
    • 3.4. Market Trends
      • 3.4.1. Upsurge In The Number Of Reagent Rental Agreements
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Autoimmune Disease Diagnostics, by Type, Application, Disease Type, Product, Test Type and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Autoimmune Disease Diagnostics (Value)
      • 5.2.1. Global Autoimmune Disease Diagnostics by: Type (Value)
        • 5.2.1.1. Systemic Diagnostics {Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus, Others}
        • 5.2.1.2. Localized Diagnostics {Multiple Sclerosis, Type 1 Diabetes, Hashimoto's Thyroiditis, Idiopathic Thrombocytopenic Purpura, Others}
      • 5.2.2. Global Autoimmune Disease Diagnostics by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Diagnostic And Research Labs
        • 5.2.2.3. Research Centers
      • 5.2.3. Global Autoimmune Disease Diagnostics by: Disease Type (Value)
        • 5.2.3.1. Rheumatoid Arthritis
        • 5.2.3.2. Systemic Lupus Erythematosus
        • 5.2.3.3. Sjögren’s Syndrome
        • 5.2.3.4. Thyroiditis
        • 5.2.3.5. Scleroderma
        • 5.2.3.6. Other Diseases
      • 5.2.4. Global Autoimmune Disease Diagnostics by: Product (Value)
        • 5.2.4.1. Consumables & Assay Kits
        • 5.2.4.2. Instruments
      • 5.2.5. Global Autoimmune Disease Diagnostics by: Test Type (Value)
        • 5.2.5.1. Routine Laboratory Tests
        • 5.2.5.2. Inflammatory Markers
        • 5.2.5.3. Autoantibodies & Immunologic Test
        • 5.2.5.4. Other Tests
      • 5.2.6. Global Autoimmune Disease Diagnostics Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
  • 6. Autoimmune Disease Diagnostics: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Thermo Fisher Scientific (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Siemens (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Abbott (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Danaher (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Bio-Rad Laboratories (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Grifols (Spain)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Trinity Biotech (Ireland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Werfen (Spain)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. HYCOR Biomedical (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. EUROIMMUN AG (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Oncimmune (United Kingdom)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. HTG Molecular Diagnostics (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Seramun Diagnostica GmbH (Germany)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
  • 7. Global Autoimmune Disease Diagnostics Sale, by Type, Application, Disease Type, Product, Test Type and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Autoimmune Disease Diagnostics (Value)
      • 7.2.1. Global Autoimmune Disease Diagnostics by: Type (Value)
        • 7.2.1.1. Systemic Diagnostics {Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus, Others}
        • 7.2.1.2. Localized Diagnostics {Multiple Sclerosis, Type 1 Diabetes, Hashimoto's Thyroiditis, Idiopathic Thrombocytopenic Purpura, Others}
      • 7.2.2. Global Autoimmune Disease Diagnostics by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Diagnostic And Research Labs
        • 7.2.2.3. Research Centers
      • 7.2.3. Global Autoimmune Disease Diagnostics by: Disease Type (Value)
        • 7.2.3.1. Rheumatoid Arthritis
        • 7.2.3.2. Systemic Lupus Erythematosus
        • 7.2.3.3. Sjögren’s Syndrome
        • 7.2.3.4. Thyroiditis
        • 7.2.3.5. Scleroderma
        • 7.2.3.6. Other Diseases
      • 7.2.4. Global Autoimmune Disease Diagnostics by: Product (Value)
        • 7.2.4.1. Consumables & Assay Kits
        • 7.2.4.2. Instruments
      • 7.2.5. Global Autoimmune Disease Diagnostics by: Test Type (Value)
        • 7.2.5.1. Routine Laboratory Tests
        • 7.2.5.2. Inflammatory Markers
        • 7.2.5.3. Autoantibodies & Immunologic Test
        • 7.2.5.4. Other Tests
      • 7.2.6. Global Autoimmune Disease Diagnostics Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Autoimmune Disease Diagnostics: by Type(USD Million)
  • Table 2. Autoimmune Disease Diagnostics Systemic Diagnostics {Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus, Others} , by Region USD Million (2018-2023)
  • Table 3. Autoimmune Disease Diagnostics Localized Diagnostics {Multiple Sclerosis, Type 1 Diabetes, Hashimoto's Thyroiditis, Idiopathic Thrombocytopenic Purpura, Others} , by Region USD Million (2018-2023)
  • Table 4. Autoimmune Disease Diagnostics: by Application(USD Million)
  • Table 5. Autoimmune Disease Diagnostics Hospitals , by Region USD Million (2018-2023)
  • Table 6. Autoimmune Disease Diagnostics Diagnostic And Research Labs , by Region USD Million (2018-2023)
  • Table 7. Autoimmune Disease Diagnostics Research Centers , by Region USD Million (2018-2023)
  • Table 8. Autoimmune Disease Diagnostics: by Disease Type(USD Million)
  • Table 9. Autoimmune Disease Diagnostics Rheumatoid Arthritis , by Region USD Million (2018-2023)
  • Table 10. Autoimmune Disease Diagnostics Systemic Lupus Erythematosus , by Region USD Million (2018-2023)
  • Table 11. Autoimmune Disease Diagnostics Sjögren’s Syndrome , by Region USD Million (2018-2023)
  • Table 12. Autoimmune Disease Diagnostics Thyroiditis , by Region USD Million (2018-2023)
  • Table 13. Autoimmune Disease Diagnostics Scleroderma , by Region USD Million (2018-2023)
  • Table 14. Autoimmune Disease Diagnostics Other Diseases , by Region USD Million (2018-2023)
  • Table 15. Autoimmune Disease Diagnostics: by Product(USD Million)
  • Table 16. Autoimmune Disease Diagnostics Consumables & Assay Kits , by Region USD Million (2018-2023)
  • Table 17. Autoimmune Disease Diagnostics Instruments , by Region USD Million (2018-2023)
  • Table 18. Autoimmune Disease Diagnostics: by Test Type(USD Million)
  • Table 19. Autoimmune Disease Diagnostics Routine Laboratory Tests , by Region USD Million (2018-2023)
  • Table 20. Autoimmune Disease Diagnostics Inflammatory Markers , by Region USD Million (2018-2023)
  • Table 21. Autoimmune Disease Diagnostics Autoantibodies & Immunologic Test , by Region USD Million (2018-2023)
  • Table 22. Autoimmune Disease Diagnostics Other Tests , by Region USD Million (2018-2023)
  • Table 23. South America Autoimmune Disease Diagnostics, by Country USD Million (2018-2023)
  • Table 24. South America Autoimmune Disease Diagnostics, by Type USD Million (2018-2023)
  • Table 25. South America Autoimmune Disease Diagnostics, by Application USD Million (2018-2023)
  • Table 26. South America Autoimmune Disease Diagnostics, by Disease Type USD Million (2018-2023)
  • Table 27. South America Autoimmune Disease Diagnostics, by Product USD Million (2018-2023)
  • Table 28. South America Autoimmune Disease Diagnostics, by Test Type USD Million (2018-2023)
  • Table 29. Brazil Autoimmune Disease Diagnostics, by Type USD Million (2018-2023)
  • Table 30. Brazil Autoimmune Disease Diagnostics, by Application USD Million (2018-2023)
  • Table 31. Brazil Autoimmune Disease Diagnostics, by Disease Type USD Million (2018-2023)
  • Table 32. Brazil Autoimmune Disease Diagnostics, by Product USD Million (2018-2023)
  • Table 33. Brazil Autoimmune Disease Diagnostics, by Test Type USD Million (2018-2023)
  • Table 34. Argentina Autoimmune Disease Diagnostics, by Type USD Million (2018-2023)
  • Table 35. Argentina Autoimmune Disease Diagnostics, by Application USD Million (2018-2023)
  • Table 36. Argentina Autoimmune Disease Diagnostics, by Disease Type USD Million (2018-2023)
  • Table 37. Argentina Autoimmune Disease Diagnostics, by Product USD Million (2018-2023)
  • Table 38. Argentina Autoimmune Disease Diagnostics, by Test Type USD Million (2018-2023)
  • Table 39. Rest of South America Autoimmune Disease Diagnostics, by Type USD Million (2018-2023)
  • Table 40. Rest of South America Autoimmune Disease Diagnostics, by Application USD Million (2018-2023)
  • Table 41. Rest of South America Autoimmune Disease Diagnostics, by Disease Type USD Million (2018-2023)
  • Table 42. Rest of South America Autoimmune Disease Diagnostics, by Product USD Million (2018-2023)
  • Table 43. Rest of South America Autoimmune Disease Diagnostics, by Test Type USD Million (2018-2023)
  • Table 44. Asia Pacific Autoimmune Disease Diagnostics, by Country USD Million (2018-2023)
  • Table 45. Asia Pacific Autoimmune Disease Diagnostics, by Type USD Million (2018-2023)
  • Table 46. Asia Pacific Autoimmune Disease Diagnostics, by Application USD Million (2018-2023)
  • Table 47. Asia Pacific Autoimmune Disease Diagnostics, by Disease Type USD Million (2018-2023)
  • Table 48. Asia Pacific Autoimmune Disease Diagnostics, by Product USD Million (2018-2023)
  • Table 49. Asia Pacific Autoimmune Disease Diagnostics, by Test Type USD Million (2018-2023)
  • Table 50. China Autoimmune Disease Diagnostics, by Type USD Million (2018-2023)
  • Table 51. China Autoimmune Disease Diagnostics, by Application USD Million (2018-2023)
  • Table 52. China Autoimmune Disease Diagnostics, by Disease Type USD Million (2018-2023)
  • Table 53. China Autoimmune Disease Diagnostics, by Product USD Million (2018-2023)
  • Table 54. China Autoimmune Disease Diagnostics, by Test Type USD Million (2018-2023)
  • Table 55. Japan Autoimmune Disease Diagnostics, by Type USD Million (2018-2023)
  • Table 56. Japan Autoimmune Disease Diagnostics, by Application USD Million (2018-2023)
  • Table 57. Japan Autoimmune Disease Diagnostics, by Disease Type USD Million (2018-2023)
  • Table 58. Japan Autoimmune Disease Diagnostics, by Product USD Million (2018-2023)
  • Table 59. Japan Autoimmune Disease Diagnostics, by Test Type USD Million (2018-2023)
  • Table 60. India Autoimmune Disease Diagnostics, by Type USD Million (2018-2023)
  • Table 61. India Autoimmune Disease Diagnostics, by Application USD Million (2018-2023)
  • Table 62. India Autoimmune Disease Diagnostics, by Disease Type USD Million (2018-2023)
  • Table 63. India Autoimmune Disease Diagnostics, by Product USD Million (2018-2023)
  • Table 64. India Autoimmune Disease Diagnostics, by Test Type USD Million (2018-2023)
  • Table 65. South Korea Autoimmune Disease Diagnostics, by Type USD Million (2018-2023)
  • Table 66. South Korea Autoimmune Disease Diagnostics, by Application USD Million (2018-2023)
  • Table 67. South Korea Autoimmune Disease Diagnostics, by Disease Type USD Million (2018-2023)
  • Table 68. South Korea Autoimmune Disease Diagnostics, by Product USD Million (2018-2023)
  • Table 69. South Korea Autoimmune Disease Diagnostics, by Test Type USD Million (2018-2023)
  • Table 70. Taiwan Autoimmune Disease Diagnostics, by Type USD Million (2018-2023)
  • Table 71. Taiwan Autoimmune Disease Diagnostics, by Application USD Million (2018-2023)
  • Table 72. Taiwan Autoimmune Disease Diagnostics, by Disease Type USD Million (2018-2023)
  • Table 73. Taiwan Autoimmune Disease Diagnostics, by Product USD Million (2018-2023)
  • Table 74. Taiwan Autoimmune Disease Diagnostics, by Test Type USD Million (2018-2023)
  • Table 75. Australia Autoimmune Disease Diagnostics, by Type USD Million (2018-2023)
  • Table 76. Australia Autoimmune Disease Diagnostics, by Application USD Million (2018-2023)
  • Table 77. Australia Autoimmune Disease Diagnostics, by Disease Type USD Million (2018-2023)
  • Table 78. Australia Autoimmune Disease Diagnostics, by Product USD Million (2018-2023)
  • Table 79. Australia Autoimmune Disease Diagnostics, by Test Type USD Million (2018-2023)
  • Table 80. Rest of Asia-Pacific Autoimmune Disease Diagnostics, by Type USD Million (2018-2023)
  • Table 81. Rest of Asia-Pacific Autoimmune Disease Diagnostics, by Application USD Million (2018-2023)
  • Table 82. Rest of Asia-Pacific Autoimmune Disease Diagnostics, by Disease Type USD Million (2018-2023)
  • Table 83. Rest of Asia-Pacific Autoimmune Disease Diagnostics, by Product USD Million (2018-2023)
  • Table 84. Rest of Asia-Pacific Autoimmune Disease Diagnostics, by Test Type USD Million (2018-2023)
  • Table 85. Europe Autoimmune Disease Diagnostics, by Country USD Million (2018-2023)
  • Table 86. Europe Autoimmune Disease Diagnostics, by Type USD Million (2018-2023)
  • Table 87. Europe Autoimmune Disease Diagnostics, by Application USD Million (2018-2023)
  • Table 88. Europe Autoimmune Disease Diagnostics, by Disease Type USD Million (2018-2023)
  • Table 89. Europe Autoimmune Disease Diagnostics, by Product USD Million (2018-2023)
  • Table 90. Europe Autoimmune Disease Diagnostics, by Test Type USD Million (2018-2023)
  • Table 91. Germany Autoimmune Disease Diagnostics, by Type USD Million (2018-2023)
  • Table 92. Germany Autoimmune Disease Diagnostics, by Application USD Million (2018-2023)
  • Table 93. Germany Autoimmune Disease Diagnostics, by Disease Type USD Million (2018-2023)
  • Table 94. Germany Autoimmune Disease Diagnostics, by Product USD Million (2018-2023)
  • Table 95. Germany Autoimmune Disease Diagnostics, by Test Type USD Million (2018-2023)
  • Table 96. France Autoimmune Disease Diagnostics, by Type USD Million (2018-2023)
  • Table 97. France Autoimmune Disease Diagnostics, by Application USD Million (2018-2023)
  • Table 98. France Autoimmune Disease Diagnostics, by Disease Type USD Million (2018-2023)
  • Table 99. France Autoimmune Disease Diagnostics, by Product USD Million (2018-2023)
  • Table 100. France Autoimmune Disease Diagnostics, by Test Type USD Million (2018-2023)
  • Table 101. Italy Autoimmune Disease Diagnostics, by Type USD Million (2018-2023)
  • Table 102. Italy Autoimmune Disease Diagnostics, by Application USD Million (2018-2023)
  • Table 103. Italy Autoimmune Disease Diagnostics, by Disease Type USD Million (2018-2023)
  • Table 104. Italy Autoimmune Disease Diagnostics, by Product USD Million (2018-2023)
  • Table 105. Italy Autoimmune Disease Diagnostics, by Test Type USD Million (2018-2023)
  • Table 106. United Kingdom Autoimmune Disease Diagnostics, by Type USD Million (2018-2023)
  • Table 107. United Kingdom Autoimmune Disease Diagnostics, by Application USD Million (2018-2023)
  • Table 108. United Kingdom Autoimmune Disease Diagnostics, by Disease Type USD Million (2018-2023)
  • Table 109. United Kingdom Autoimmune Disease Diagnostics, by Product USD Million (2018-2023)
  • Table 110. United Kingdom Autoimmune Disease Diagnostics, by Test Type USD Million (2018-2023)
  • Table 111. Netherlands Autoimmune Disease Diagnostics, by Type USD Million (2018-2023)
  • Table 112. Netherlands Autoimmune Disease Diagnostics, by Application USD Million (2018-2023)
  • Table 113. Netherlands Autoimmune Disease Diagnostics, by Disease Type USD Million (2018-2023)
  • Table 114. Netherlands Autoimmune Disease Diagnostics, by Product USD Million (2018-2023)
  • Table 115. Netherlands Autoimmune Disease Diagnostics, by Test Type USD Million (2018-2023)
  • Table 116. Rest of Europe Autoimmune Disease Diagnostics, by Type USD Million (2018-2023)
  • Table 117. Rest of Europe Autoimmune Disease Diagnostics, by Application USD Million (2018-2023)
  • Table 118. Rest of Europe Autoimmune Disease Diagnostics, by Disease Type USD Million (2018-2023)
  • Table 119. Rest of Europe Autoimmune Disease Diagnostics, by Product USD Million (2018-2023)
  • Table 120. Rest of Europe Autoimmune Disease Diagnostics, by Test Type USD Million (2018-2023)
  • Table 121. MEA Autoimmune Disease Diagnostics, by Country USD Million (2018-2023)
  • Table 122. MEA Autoimmune Disease Diagnostics, by Type USD Million (2018-2023)
  • Table 123. MEA Autoimmune Disease Diagnostics, by Application USD Million (2018-2023)
  • Table 124. MEA Autoimmune Disease Diagnostics, by Disease Type USD Million (2018-2023)
  • Table 125. MEA Autoimmune Disease Diagnostics, by Product USD Million (2018-2023)
  • Table 126. MEA Autoimmune Disease Diagnostics, by Test Type USD Million (2018-2023)
  • Table 127. Middle East Autoimmune Disease Diagnostics, by Type USD Million (2018-2023)
  • Table 128. Middle East Autoimmune Disease Diagnostics, by Application USD Million (2018-2023)
  • Table 129. Middle East Autoimmune Disease Diagnostics, by Disease Type USD Million (2018-2023)
  • Table 130. Middle East Autoimmune Disease Diagnostics, by Product USD Million (2018-2023)
  • Table 131. Middle East Autoimmune Disease Diagnostics, by Test Type USD Million (2018-2023)
  • Table 132. Africa Autoimmune Disease Diagnostics, by Type USD Million (2018-2023)
  • Table 133. Africa Autoimmune Disease Diagnostics, by Application USD Million (2018-2023)
  • Table 134. Africa Autoimmune Disease Diagnostics, by Disease Type USD Million (2018-2023)
  • Table 135. Africa Autoimmune Disease Diagnostics, by Product USD Million (2018-2023)
  • Table 136. Africa Autoimmune Disease Diagnostics, by Test Type USD Million (2018-2023)
  • Table 137. North America Autoimmune Disease Diagnostics, by Country USD Million (2018-2023)
  • Table 138. North America Autoimmune Disease Diagnostics, by Type USD Million (2018-2023)
  • Table 139. North America Autoimmune Disease Diagnostics, by Application USD Million (2018-2023)
  • Table 140. North America Autoimmune Disease Diagnostics, by Disease Type USD Million (2018-2023)
  • Table 141. North America Autoimmune Disease Diagnostics, by Product USD Million (2018-2023)
  • Table 142. North America Autoimmune Disease Diagnostics, by Test Type USD Million (2018-2023)
  • Table 143. United States Autoimmune Disease Diagnostics, by Type USD Million (2018-2023)
  • Table 144. United States Autoimmune Disease Diagnostics, by Application USD Million (2018-2023)
  • Table 145. United States Autoimmune Disease Diagnostics, by Disease Type USD Million (2018-2023)
  • Table 146. United States Autoimmune Disease Diagnostics, by Product USD Million (2018-2023)
  • Table 147. United States Autoimmune Disease Diagnostics, by Test Type USD Million (2018-2023)
  • Table 148. Canada Autoimmune Disease Diagnostics, by Type USD Million (2018-2023)
  • Table 149. Canada Autoimmune Disease Diagnostics, by Application USD Million (2018-2023)
  • Table 150. Canada Autoimmune Disease Diagnostics, by Disease Type USD Million (2018-2023)
  • Table 151. Canada Autoimmune Disease Diagnostics, by Product USD Million (2018-2023)
  • Table 152. Canada Autoimmune Disease Diagnostics, by Test Type USD Million (2018-2023)
  • Table 153. Mexico Autoimmune Disease Diagnostics, by Type USD Million (2018-2023)
  • Table 154. Mexico Autoimmune Disease Diagnostics, by Application USD Million (2018-2023)
  • Table 155. Mexico Autoimmune Disease Diagnostics, by Disease Type USD Million (2018-2023)
  • Table 156. Mexico Autoimmune Disease Diagnostics, by Product USD Million (2018-2023)
  • Table 157. Mexico Autoimmune Disease Diagnostics, by Test Type USD Million (2018-2023)
  • Table 158. Company Basic Information, Sales Area and Its Competitors
  • Table 159. Company Basic Information, Sales Area and Its Competitors
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Company Basic Information, Sales Area and Its Competitors
  • Table 167. Company Basic Information, Sales Area and Its Competitors
  • Table 168. Company Basic Information, Sales Area and Its Competitors
  • Table 169. Company Basic Information, Sales Area and Its Competitors
  • Table 170. Company Basic Information, Sales Area and Its Competitors
  • Table 171. Autoimmune Disease Diagnostics: by Type(USD Million)
  • Table 172. Autoimmune Disease Diagnostics Systemic Diagnostics {Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus, Others} , by Region USD Million (2025-2030)
  • Table 173. Autoimmune Disease Diagnostics Localized Diagnostics {Multiple Sclerosis, Type 1 Diabetes, Hashimoto's Thyroiditis, Idiopathic Thrombocytopenic Purpura, Others} , by Region USD Million (2025-2030)
  • Table 174. Autoimmune Disease Diagnostics: by Application(USD Million)
  • Table 175. Autoimmune Disease Diagnostics Hospitals , by Region USD Million (2025-2030)
  • Table 176. Autoimmune Disease Diagnostics Diagnostic And Research Labs , by Region USD Million (2025-2030)
  • Table 177. Autoimmune Disease Diagnostics Research Centers , by Region USD Million (2025-2030)
  • Table 178. Autoimmune Disease Diagnostics: by Disease Type(USD Million)
  • Table 179. Autoimmune Disease Diagnostics Rheumatoid Arthritis , by Region USD Million (2025-2030)
  • Table 180. Autoimmune Disease Diagnostics Systemic Lupus Erythematosus , by Region USD Million (2025-2030)
  • Table 181. Autoimmune Disease Diagnostics Sjögren’s Syndrome , by Region USD Million (2025-2030)
  • Table 182. Autoimmune Disease Diagnostics Thyroiditis , by Region USD Million (2025-2030)
  • Table 183. Autoimmune Disease Diagnostics Scleroderma , by Region USD Million (2025-2030)
  • Table 184. Autoimmune Disease Diagnostics Other Diseases , by Region USD Million (2025-2030)
  • Table 185. Autoimmune Disease Diagnostics: by Product(USD Million)
  • Table 186. Autoimmune Disease Diagnostics Consumables & Assay Kits , by Region USD Million (2025-2030)
  • Table 187. Autoimmune Disease Diagnostics Instruments , by Region USD Million (2025-2030)
  • Table 188. Autoimmune Disease Diagnostics: by Test Type(USD Million)
  • Table 189. Autoimmune Disease Diagnostics Routine Laboratory Tests , by Region USD Million (2025-2030)
  • Table 190. Autoimmune Disease Diagnostics Inflammatory Markers , by Region USD Million (2025-2030)
  • Table 191. Autoimmune Disease Diagnostics Autoantibodies & Immunologic Test , by Region USD Million (2025-2030)
  • Table 192. Autoimmune Disease Diagnostics Other Tests , by Region USD Million (2025-2030)
  • Table 193. South America Autoimmune Disease Diagnostics, by Country USD Million (2025-2030)
  • Table 194. South America Autoimmune Disease Diagnostics, by Type USD Million (2025-2030)
  • Table 195. South America Autoimmune Disease Diagnostics, by Application USD Million (2025-2030)
  • Table 196. South America Autoimmune Disease Diagnostics, by Disease Type USD Million (2025-2030)
  • Table 197. South America Autoimmune Disease Diagnostics, by Product USD Million (2025-2030)
  • Table 198. South America Autoimmune Disease Diagnostics, by Test Type USD Million (2025-2030)
  • Table 199. Brazil Autoimmune Disease Diagnostics, by Type USD Million (2025-2030)
  • Table 200. Brazil Autoimmune Disease Diagnostics, by Application USD Million (2025-2030)
  • Table 201. Brazil Autoimmune Disease Diagnostics, by Disease Type USD Million (2025-2030)
  • Table 202. Brazil Autoimmune Disease Diagnostics, by Product USD Million (2025-2030)
  • Table 203. Brazil Autoimmune Disease Diagnostics, by Test Type USD Million (2025-2030)
  • Table 204. Argentina Autoimmune Disease Diagnostics, by Type USD Million (2025-2030)
  • Table 205. Argentina Autoimmune Disease Diagnostics, by Application USD Million (2025-2030)
  • Table 206. Argentina Autoimmune Disease Diagnostics, by Disease Type USD Million (2025-2030)
  • Table 207. Argentina Autoimmune Disease Diagnostics, by Product USD Million (2025-2030)
  • Table 208. Argentina Autoimmune Disease Diagnostics, by Test Type USD Million (2025-2030)
  • Table 209. Rest of South America Autoimmune Disease Diagnostics, by Type USD Million (2025-2030)
  • Table 210. Rest of South America Autoimmune Disease Diagnostics, by Application USD Million (2025-2030)
  • Table 211. Rest of South America Autoimmune Disease Diagnostics, by Disease Type USD Million (2025-2030)
  • Table 212. Rest of South America Autoimmune Disease Diagnostics, by Product USD Million (2025-2030)
  • Table 213. Rest of South America Autoimmune Disease Diagnostics, by Test Type USD Million (2025-2030)
  • Table 214. Asia Pacific Autoimmune Disease Diagnostics, by Country USD Million (2025-2030)
  • Table 215. Asia Pacific Autoimmune Disease Diagnostics, by Type USD Million (2025-2030)
  • Table 216. Asia Pacific Autoimmune Disease Diagnostics, by Application USD Million (2025-2030)
  • Table 217. Asia Pacific Autoimmune Disease Diagnostics, by Disease Type USD Million (2025-2030)
  • Table 218. Asia Pacific Autoimmune Disease Diagnostics, by Product USD Million (2025-2030)
  • Table 219. Asia Pacific Autoimmune Disease Diagnostics, by Test Type USD Million (2025-2030)
  • Table 220. China Autoimmune Disease Diagnostics, by Type USD Million (2025-2030)
  • Table 221. China Autoimmune Disease Diagnostics, by Application USD Million (2025-2030)
  • Table 222. China Autoimmune Disease Diagnostics, by Disease Type USD Million (2025-2030)
  • Table 223. China Autoimmune Disease Diagnostics, by Product USD Million (2025-2030)
  • Table 224. China Autoimmune Disease Diagnostics, by Test Type USD Million (2025-2030)
  • Table 225. Japan Autoimmune Disease Diagnostics, by Type USD Million (2025-2030)
  • Table 226. Japan Autoimmune Disease Diagnostics, by Application USD Million (2025-2030)
  • Table 227. Japan Autoimmune Disease Diagnostics, by Disease Type USD Million (2025-2030)
  • Table 228. Japan Autoimmune Disease Diagnostics, by Product USD Million (2025-2030)
  • Table 229. Japan Autoimmune Disease Diagnostics, by Test Type USD Million (2025-2030)
  • Table 230. India Autoimmune Disease Diagnostics, by Type USD Million (2025-2030)
  • Table 231. India Autoimmune Disease Diagnostics, by Application USD Million (2025-2030)
  • Table 232. India Autoimmune Disease Diagnostics, by Disease Type USD Million (2025-2030)
  • Table 233. India Autoimmune Disease Diagnostics, by Product USD Million (2025-2030)
  • Table 234. India Autoimmune Disease Diagnostics, by Test Type USD Million (2025-2030)
  • Table 235. South Korea Autoimmune Disease Diagnostics, by Type USD Million (2025-2030)
  • Table 236. South Korea Autoimmune Disease Diagnostics, by Application USD Million (2025-2030)
  • Table 237. South Korea Autoimmune Disease Diagnostics, by Disease Type USD Million (2025-2030)
  • Table 238. South Korea Autoimmune Disease Diagnostics, by Product USD Million (2025-2030)
  • Table 239. South Korea Autoimmune Disease Diagnostics, by Test Type USD Million (2025-2030)
  • Table 240. Taiwan Autoimmune Disease Diagnostics, by Type USD Million (2025-2030)
  • Table 241. Taiwan Autoimmune Disease Diagnostics, by Application USD Million (2025-2030)
  • Table 242. Taiwan Autoimmune Disease Diagnostics, by Disease Type USD Million (2025-2030)
  • Table 243. Taiwan Autoimmune Disease Diagnostics, by Product USD Million (2025-2030)
  • Table 244. Taiwan Autoimmune Disease Diagnostics, by Test Type USD Million (2025-2030)
  • Table 245. Australia Autoimmune Disease Diagnostics, by Type USD Million (2025-2030)
  • Table 246. Australia Autoimmune Disease Diagnostics, by Application USD Million (2025-2030)
  • Table 247. Australia Autoimmune Disease Diagnostics, by Disease Type USD Million (2025-2030)
  • Table 248. Australia Autoimmune Disease Diagnostics, by Product USD Million (2025-2030)
  • Table 249. Australia Autoimmune Disease Diagnostics, by Test Type USD Million (2025-2030)
  • Table 250. Rest of Asia-Pacific Autoimmune Disease Diagnostics, by Type USD Million (2025-2030)
  • Table 251. Rest of Asia-Pacific Autoimmune Disease Diagnostics, by Application USD Million (2025-2030)
  • Table 252. Rest of Asia-Pacific Autoimmune Disease Diagnostics, by Disease Type USD Million (2025-2030)
  • Table 253. Rest of Asia-Pacific Autoimmune Disease Diagnostics, by Product USD Million (2025-2030)
  • Table 254. Rest of Asia-Pacific Autoimmune Disease Diagnostics, by Test Type USD Million (2025-2030)
  • Table 255. Europe Autoimmune Disease Diagnostics, by Country USD Million (2025-2030)
  • Table 256. Europe Autoimmune Disease Diagnostics, by Type USD Million (2025-2030)
  • Table 257. Europe Autoimmune Disease Diagnostics, by Application USD Million (2025-2030)
  • Table 258. Europe Autoimmune Disease Diagnostics, by Disease Type USD Million (2025-2030)
  • Table 259. Europe Autoimmune Disease Diagnostics, by Product USD Million (2025-2030)
  • Table 260. Europe Autoimmune Disease Diagnostics, by Test Type USD Million (2025-2030)
  • Table 261. Germany Autoimmune Disease Diagnostics, by Type USD Million (2025-2030)
  • Table 262. Germany Autoimmune Disease Diagnostics, by Application USD Million (2025-2030)
  • Table 263. Germany Autoimmune Disease Diagnostics, by Disease Type USD Million (2025-2030)
  • Table 264. Germany Autoimmune Disease Diagnostics, by Product USD Million (2025-2030)
  • Table 265. Germany Autoimmune Disease Diagnostics, by Test Type USD Million (2025-2030)
  • Table 266. France Autoimmune Disease Diagnostics, by Type USD Million (2025-2030)
  • Table 267. France Autoimmune Disease Diagnostics, by Application USD Million (2025-2030)
  • Table 268. France Autoimmune Disease Diagnostics, by Disease Type USD Million (2025-2030)
  • Table 269. France Autoimmune Disease Diagnostics, by Product USD Million (2025-2030)
  • Table 270. France Autoimmune Disease Diagnostics, by Test Type USD Million (2025-2030)
  • Table 271. Italy Autoimmune Disease Diagnostics, by Type USD Million (2025-2030)
  • Table 272. Italy Autoimmune Disease Diagnostics, by Application USD Million (2025-2030)
  • Table 273. Italy Autoimmune Disease Diagnostics, by Disease Type USD Million (2025-2030)
  • Table 274. Italy Autoimmune Disease Diagnostics, by Product USD Million (2025-2030)
  • Table 275. Italy Autoimmune Disease Diagnostics, by Test Type USD Million (2025-2030)
  • Table 276. United Kingdom Autoimmune Disease Diagnostics, by Type USD Million (2025-2030)
  • Table 277. United Kingdom Autoimmune Disease Diagnostics, by Application USD Million (2025-2030)
  • Table 278. United Kingdom Autoimmune Disease Diagnostics, by Disease Type USD Million (2025-2030)
  • Table 279. United Kingdom Autoimmune Disease Diagnostics, by Product USD Million (2025-2030)
  • Table 280. United Kingdom Autoimmune Disease Diagnostics, by Test Type USD Million (2025-2030)
  • Table 281. Netherlands Autoimmune Disease Diagnostics, by Type USD Million (2025-2030)
  • Table 282. Netherlands Autoimmune Disease Diagnostics, by Application USD Million (2025-2030)
  • Table 283. Netherlands Autoimmune Disease Diagnostics, by Disease Type USD Million (2025-2030)
  • Table 284. Netherlands Autoimmune Disease Diagnostics, by Product USD Million (2025-2030)
  • Table 285. Netherlands Autoimmune Disease Diagnostics, by Test Type USD Million (2025-2030)
  • Table 286. Rest of Europe Autoimmune Disease Diagnostics, by Type USD Million (2025-2030)
  • Table 287. Rest of Europe Autoimmune Disease Diagnostics, by Application USD Million (2025-2030)
  • Table 288. Rest of Europe Autoimmune Disease Diagnostics, by Disease Type USD Million (2025-2030)
  • Table 289. Rest of Europe Autoimmune Disease Diagnostics, by Product USD Million (2025-2030)
  • Table 290. Rest of Europe Autoimmune Disease Diagnostics, by Test Type USD Million (2025-2030)
  • Table 291. MEA Autoimmune Disease Diagnostics, by Country USD Million (2025-2030)
  • Table 292. MEA Autoimmune Disease Diagnostics, by Type USD Million (2025-2030)
  • Table 293. MEA Autoimmune Disease Diagnostics, by Application USD Million (2025-2030)
  • Table 294. MEA Autoimmune Disease Diagnostics, by Disease Type USD Million (2025-2030)
  • Table 295. MEA Autoimmune Disease Diagnostics, by Product USD Million (2025-2030)
  • Table 296. MEA Autoimmune Disease Diagnostics, by Test Type USD Million (2025-2030)
  • Table 297. Middle East Autoimmune Disease Diagnostics, by Type USD Million (2025-2030)
  • Table 298. Middle East Autoimmune Disease Diagnostics, by Application USD Million (2025-2030)
  • Table 299. Middle East Autoimmune Disease Diagnostics, by Disease Type USD Million (2025-2030)
  • Table 300. Middle East Autoimmune Disease Diagnostics, by Product USD Million (2025-2030)
  • Table 301. Middle East Autoimmune Disease Diagnostics, by Test Type USD Million (2025-2030)
  • Table 302. Africa Autoimmune Disease Diagnostics, by Type USD Million (2025-2030)
  • Table 303. Africa Autoimmune Disease Diagnostics, by Application USD Million (2025-2030)
  • Table 304. Africa Autoimmune Disease Diagnostics, by Disease Type USD Million (2025-2030)
  • Table 305. Africa Autoimmune Disease Diagnostics, by Product USD Million (2025-2030)
  • Table 306. Africa Autoimmune Disease Diagnostics, by Test Type USD Million (2025-2030)
  • Table 307. North America Autoimmune Disease Diagnostics, by Country USD Million (2025-2030)
  • Table 308. North America Autoimmune Disease Diagnostics, by Type USD Million (2025-2030)
  • Table 309. North America Autoimmune Disease Diagnostics, by Application USD Million (2025-2030)
  • Table 310. North America Autoimmune Disease Diagnostics, by Disease Type USD Million (2025-2030)
  • Table 311. North America Autoimmune Disease Diagnostics, by Product USD Million (2025-2030)
  • Table 312. North America Autoimmune Disease Diagnostics, by Test Type USD Million (2025-2030)
  • Table 313. United States Autoimmune Disease Diagnostics, by Type USD Million (2025-2030)
  • Table 314. United States Autoimmune Disease Diagnostics, by Application USD Million (2025-2030)
  • Table 315. United States Autoimmune Disease Diagnostics, by Disease Type USD Million (2025-2030)
  • Table 316. United States Autoimmune Disease Diagnostics, by Product USD Million (2025-2030)
  • Table 317. United States Autoimmune Disease Diagnostics, by Test Type USD Million (2025-2030)
  • Table 318. Canada Autoimmune Disease Diagnostics, by Type USD Million (2025-2030)
  • Table 319. Canada Autoimmune Disease Diagnostics, by Application USD Million (2025-2030)
  • Table 320. Canada Autoimmune Disease Diagnostics, by Disease Type USD Million (2025-2030)
  • Table 321. Canada Autoimmune Disease Diagnostics, by Product USD Million (2025-2030)
  • Table 322. Canada Autoimmune Disease Diagnostics, by Test Type USD Million (2025-2030)
  • Table 323. Mexico Autoimmune Disease Diagnostics, by Type USD Million (2025-2030)
  • Table 324. Mexico Autoimmune Disease Diagnostics, by Application USD Million (2025-2030)
  • Table 325. Mexico Autoimmune Disease Diagnostics, by Disease Type USD Million (2025-2030)
  • Table 326. Mexico Autoimmune Disease Diagnostics, by Product USD Million (2025-2030)
  • Table 327. Mexico Autoimmune Disease Diagnostics, by Test Type USD Million (2025-2030)
  • Table 328. Research Programs/Design for This Report
  • Table 329. Key Data Information from Secondary Sources
  • Table 330. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Autoimmune Disease Diagnostics: by Type USD Million (2018-2023)
  • Figure 5. Global Autoimmune Disease Diagnostics: by Application USD Million (2018-2023)
  • Figure 6. Global Autoimmune Disease Diagnostics: by Disease Type USD Million (2018-2023)
  • Figure 7. Global Autoimmune Disease Diagnostics: by Product USD Million (2018-2023)
  • Figure 8. Global Autoimmune Disease Diagnostics: by Test Type USD Million (2018-2023)
  • Figure 9. South America Autoimmune Disease Diagnostics Share (%), by Country
  • Figure 10. Asia Pacific Autoimmune Disease Diagnostics Share (%), by Country
  • Figure 11. Europe Autoimmune Disease Diagnostics Share (%), by Country
  • Figure 12. MEA Autoimmune Disease Diagnostics Share (%), by Country
  • Figure 13. North America Autoimmune Disease Diagnostics Share (%), by Country
  • Figure 14. Global Autoimmune Disease Diagnostics share by Players 2023 (%)
  • Figure 15. Global Autoimmune Disease Diagnostics share by Players (Top 3) 2023(%)
  • Figure 16. Global Autoimmune Disease Diagnostics share by Players (Top 5) 2023(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 19. Thermo Fisher Scientific (United States) Revenue: by Geography 2023
  • Figure 20. Siemens (Germany) Revenue, Net Income and Gross profit
  • Figure 21. Siemens (Germany) Revenue: by Geography 2023
  • Figure 22. Abbott (United States) Revenue, Net Income and Gross profit
  • Figure 23. Abbott (United States) Revenue: by Geography 2023
  • Figure 24. Danaher (United States) Revenue, Net Income and Gross profit
  • Figure 25. Danaher (United States) Revenue: by Geography 2023
  • Figure 26. Bio-Rad Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 27. Bio-Rad Laboratories (United States) Revenue: by Geography 2023
  • Figure 28. Grifols (Spain) Revenue, Net Income and Gross profit
  • Figure 29. Grifols (Spain) Revenue: by Geography 2023
  • Figure 30. Trinity Biotech (Ireland) Revenue, Net Income and Gross profit
  • Figure 31. Trinity Biotech (Ireland) Revenue: by Geography 2023
  • Figure 32. Werfen (Spain) Revenue, Net Income and Gross profit
  • Figure 33. Werfen (Spain) Revenue: by Geography 2023
  • Figure 34. HYCOR Biomedical (United States) Revenue, Net Income and Gross profit
  • Figure 35. HYCOR Biomedical (United States) Revenue: by Geography 2023
  • Figure 36. EUROIMMUN AG (Germany) Revenue, Net Income and Gross profit
  • Figure 37. EUROIMMUN AG (Germany) Revenue: by Geography 2023
  • Figure 38. Oncimmune (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 39. Oncimmune (United Kingdom) Revenue: by Geography 2023
  • Figure 40. HTG Molecular Diagnostics (United States) Revenue, Net Income and Gross profit
  • Figure 41. HTG Molecular Diagnostics (United States) Revenue: by Geography 2023
  • Figure 42. Seramun Diagnostica GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 43. Seramun Diagnostica GmbH (Germany) Revenue: by Geography 2023
  • Figure 44. Global Autoimmune Disease Diagnostics: by Type USD Million (2025-2030)
  • Figure 45. Global Autoimmune Disease Diagnostics: by Application USD Million (2025-2030)
  • Figure 46. Global Autoimmune Disease Diagnostics: by Disease Type USD Million (2025-2030)
  • Figure 47. Global Autoimmune Disease Diagnostics: by Product USD Million (2025-2030)
  • Figure 48. Global Autoimmune Disease Diagnostics: by Test Type USD Million (2025-2030)
  • Figure 49. South America Autoimmune Disease Diagnostics Share (%), by Country
  • Figure 50. Asia Pacific Autoimmune Disease Diagnostics Share (%), by Country
  • Figure 51. Europe Autoimmune Disease Diagnostics Share (%), by Country
  • Figure 52. MEA Autoimmune Disease Diagnostics Share (%), by Country
  • Figure 53. North America Autoimmune Disease Diagnostics Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Thermo Fisher Scientific (United States)
  • Siemens (Germany)
  • Abbott (United States)
  • Danaher (United States)
  • Bio-Rad Laboratories (United States)
  • Grifols (Spain)
  • Trinity Biotech (Ireland)
  • Werfen (Spain)
  • HYCOR Biomedical (United States)
  • EUROIMMUN AG (Germany)
  • Oncimmune (United Kingdom)
  • HTG Molecular Diagnostics (United States)
  • Seramun Diagnostica GmbH (Germany)
Additional players considered in the study are as follows:
Exagen Inc. (United States) , Cambridge Life Sciences Limited (United Kingdom) , A. Menarini Diagnostics s.r.l (Italy) , ORGENTEC Diagnostika (Germany) , KRONUS (United States) , AESKU GROUP GMBH & CO. KG (Germany).
Select User Access Type

Key Highlights of Report


Jan 2024 209 Pages 97 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Autoimmune Disease Diagnostics research Quantitative research analysis
Global Autoimmune Disease Diagnostics research Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Thermo Fisher Scientific (United States), Siemens (Germany), Abbott (United States), Danaher (United States), Bio-Rad Laboratories (United States), Grifols (Spain), Trinity Biotech (Ireland), Werfen (Spain), HYCOR Biomedical (United States), EUROIMMUN AG (Germany), Oncimmune (United Kingdom), HTG Molecular Diagnostics (United States) and Seramun Diagnostica GmbH (Germany) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Upsurge In The Number Of Reagent Rental Agreements" is seen as one of major influencing trends for Autoimmune Disease Diagnostics Market during projected period 2023-2030.
The Autoimmune Disease Diagnostics market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Autoimmune Disease Diagnostics research Report?

Have a Query? Click Here

Other Related Reports

Eye Drops Comprehensive Study by Type (Steroid and Antibiotic Eye Drops, Glaucoma Drops, Anti-Allergic Eye Drops, Mydriatic Eye Drops, Redness-Relieving Drops, Others), Application (Eye Diseases, Gla...
$ 3650
Bleeding Disorders Treatment Comprehensive Study by Type (Hemophilia A, Hemophilia B, Von Willebrand Disease, Others), Application (Hospital, Research Institutes, Others), Drug Class (Plasma-Derived ...
$ 3650
Renal Disease Comprehensive Study by Disease Type (Chronic Kidney Disease, Kidney Stones, Glomerulonephritis, Polycystic Kidney Disease, Urinary Tract Infections), Treatment (Medication, Dialysis (Ha...
$ 3800
Hormone Replacement Therapy Comprehensive Study by Type (Estrogen replacement therapy, Growth hormone replacement therapy, Thyroid Hormone Replacement Therapy, Testosterone Hormone Replacement Therap...
$ 3350
Panic Attack Treatment Comprehensive Study by Type (Spontaneous Panic Attacks, Situationally Bound Panic Attacks, Situationally Predisposed Panic Attacks), End Users (Adults, Children and Adolescents...
$ 3500
Hirsutism-Treatment Comprehensive Study by Type (Idiopathic Hirsutism, Secondary Hirsutism, Others), Application (Hospitals and Clinics, Medical Research Laboratories, Academic Institutes), Treatment...
$ 3750